Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 safety, tolerability, and pharmacokinetics study of intravenous Minocin in healthy adults
NL-OMON45336Phase 1Active, not recruiting
- Sponsor
- The Medicines Company
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in Acinetobacter infection comparing Minocin IV with Placebo (2 arms). Primary endpoint: Safety and tolerability of single and multiple intravenous doses of Minocin IV. Started Apr 2017; status: active, not recruiting.
02
Drugs
minocycline
03
Conditions
Acinetobacter infection
Beyond the preview
Go deeper on NL-OMON45336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45336.